Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma
Name
Mito-2009-Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic SarcomaMalignant Fibrous Histiocytoma.pdf
Size
498.39 KB
Format
Adobe PDF
Checksum (MD5)
76e2fbb1ffc4adbf0f9a6783b3502afa
Author(s) • • • • • • • • •
Kirsch, David G.
Mukherjee, Sayan
Lev, Dina
Brigman, Brian E.
Yoon, Sam S.
Hornicek, Francis J.
Eward, William C.
Stangenberg, Lars
Dodd, Rebecca D.
Lazar, Alexander J.
Date Issued
November 2009
Journal
PLoS ONE
Publisher
Public Library of Science
Citation
Mito, Jeffrey K. et al. “Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma.” PLoS ONE 4.11 (2009): e8075.
Version
Final published version
Abstract
Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-Kras[superscript G12D]; Trp53[superscript Flox/Flox] mouse model of soft tissue sarcoma that is highly enriched in human MFH. With this mouse geneset as a filter, we identify expression of the RAS target FOXM1 in human MFH. Expression of Foxm1 is elevated in mouse sarcomas that metastasize to the lung and tissue microarray analysis of human MFH correlates overexpression of FOXM1 with metastasis. These results suggest that genomic alterations present in human MFH are conserved in the LSL-Kras[superscript G12D]; p53[superscript Flox/Flox] mouse model of soft tissue sarcoma and demonstrate the utility of this pre-clinical model.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
http://dx.doi.org/10.1371/journal.pone.0008075